Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Severe Aortic Stenosis clinical trials
1 of 3 indexed Severe Aortic Stenosis trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Severe Aortic Stenosis: 3 US clinical trials tracked, 1 recruiting.
Severe Aortic Stenosis is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Medtronic Cardiovascular, running 2 of these trials.
Enrollment posture brief
Registry condition severe-aortic-stenosis
OPEN 1 | RECR 33% | LATE 0 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Severe Aortic Stenosis lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Severe Aortic Stenosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Severe Aortic Stenosis is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
Atlantic Health System
NCT07309029
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Medtronic Cardiovascular
NCT01586910
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
Medtronic Cardiovascular
NCT01675440
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Severe Aortic Stenosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Severe Aortic Stenosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Severe Aortic Stenosis page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Severe Aortic Stenosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Medtronic Cardiovascular sponsors the most Severe Aortic Stenosis trials on record, review their full trial history before evaluating a specific study. See Medtronic Cardiovascular's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Severe Aortic Stenosis condition card totals 3 registered trials; most-linked intervention Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.